LADENBURG THALMANN FINANCIAL SERVICES INC. - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 187 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 5.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$275,000
-12.7%
11,498
-2.3%
0.00%0.0%
Q3 2019$315,000
-21.8%
11,768
-21.0%
0.00%
-33.3%
Q2 2019$403,000
+41.4%
14,900
+81.9%
0.00%
+50.0%
Q1 2019$285,000
+90.0%
8,190
+7.0%
0.00%
+100.0%
Q4 2018$150,000
-30.6%
7,652
-5.6%
0.00%
-50.0%
Q3 2018$216,000
-11.8%
8,110
+7.8%
0.00%0.0%
Q2 2018$245,0000.0%7,5240.0%0.00%0.0%
Q1 2018$245,000
-31.2%
7,524
+2.9%
0.00%
-33.3%
Q4 2017$356,000
-6.1%
7,314
+4.3%
0.00%
-25.0%
Q3 2017$379,000
+3.0%
7,014
+7.0%
0.00%0.0%
Q2 2017$368,000
+43.8%
6,554
+0.2%
0.00%
+33.3%
Q1 2017$256,000
+59.0%
6,543
-8.5%
0.00%
+50.0%
Q4 2016$161,000
-13.9%
7,148
-13.3%
0.00%
-33.3%
Q3 2016$187,000
-2.1%
8,245
+1.8%
0.00%0.0%
Q2 2016$191,000
+30.8%
8,101
+13.2%
0.00%0.0%
Q1 2016$146,000
-60.8%
7,157
-1.0%
0.00%
-57.1%
Q4 2015$372,000
+39.3%
7,232
+15.3%
0.01%
+16.7%
Q3 2015$267,000
+73.4%
6,273
+84.6%
0.01%
+100.0%
Q2 2015$154,000
+97.4%
3,398
+65.9%
0.00%
+200.0%
Q1 2015$78,000
+36.8%
2,048
+2.4%
0.00%0.0%
Q4 2014$57,0002,0000.00%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 232,952$5,498,0005.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,673,727$86,700,0003.41%
Redmile Group, LLC 1,466,537$34,610,0003.31%
SECTORAL ASSET MANAGEMENT INC 1,229,382$29,013,0003.00%
HARVEY CAPITAL MANAGEMENT INC 206,530$4,874,0002.44%
Marcus Capital, LLC 75,150$1,774,0001.87%
Cormorant Asset Management, LP 396,000$9,346,0001.32%
Rail-Splitter Capital Management, LLC 221,414$5,225,0001.25%
Temasek Holdings (Private) Ltd 6,583,568$155,372,0001.21%
EMERALD MUTUAL FUND ADVISERS TRUST 636,526$15,022,0000.84%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders